menu search

Cardiac implantable electronic devices market surpasses usd 16.1 bn by 2031 owing to surge in adoption of implantable loop recorder: transparency market research

Cardiac implantable electronic devices (CIEDs) is anticipated to have a significant demand among the elderly patient ...

June 12, 2023, 2:30 pm

Here's why you should hold american equity (ael) stock for now

AEL 2.0 strategy, strong annuity product sales and an aging U.S. population poise American Equity (AEL)...

June 12, 2023, 1:43 pm

Canada employment down -17.3k in may, unemployment rate rose to 5.2%

Canada employment dropped -17.3k, or -0.1% mom in May, worse than expectation of 21.2k growth. That compared to average 33k monthly growth from Februa...

June 9, 2023, 12:38 pm

Amgen: big yield and dividend growth on sale now

The article analyzes Amgen's financial performance, including balance sheet trends, valuation models, and competition & margin trends. We'll discuss A...

June 8, 2023, 11:21 pm

Northwest natural holding: a solid high-yield utility for an economic downturn

Northwest Natural Holding Company is primarily a regulated gas utility serving the Pacific Northwest. The company is largely immune to macroeconomic s...

June 8, 2023, 5:50 pm

Can payments innovation enable financial inclusion or empower the unbanked?

Financial inclusion, or having access to and using affordable financial services, has become a key factor in global economic growth and the eradicatio...

June 6, 2023, 10:04 pm

Varicose veins treatment market on an upward trajectory, estimated to surpass usd 2.4 bn by 2031: tmr study highlights growth factors

Considerable adoption of compression stockings as a non-surgical or supportive treatment among the patient pop...

June 6, 2023, 5:30 pm

Have $1,000? 2 warren buffett stocks to buy

After a brutal sell-off during the pandemic, massive revenue growth and profits could spur a recovery. Nu Holdings grew revenue at a rapid pace as it ...

June 6, 2023, 9:02 am

Whitestone reit: crisis resistant retail trading 50 cents on the dollar

Whitestone REIT focuses on service-oriented strip malls in rapidly growing cities in the Sunbelt, benefiting from ...

June 6, 2023, 8:58 am

Meta platforms continues its turnaround and things are heating up

Meta Platforms has seen significant reductions in operational costs and increased free cash flow since implementing efficiency measures, with the pote...

June 6, 2023, 8:45 am

Sutro biopharma announces oral presentation at asco 2023 featuring data for luveltamab tazevibulin from the phase 1 dose-expansion study in ovarian cancer and the initiation of the phase 2/3 pivotal s

– Consistent with data shared in January 2023, the presentation at ASCO 2023 highlights data from the Phase 1 dose-expansion study for luveltamab ta...

June 3, 2023, 8:00 pm

Sutro biopharma announces oral presentation at asco 2023 featuring data for luveltamab tazevibulin from the phase 1 dose-expansion study in ovarian cancer and the initiation of the phase 2/3 pivotal s

– Consistent with data shared in January 2023, the presentation at ASCO 2023 highlights data from the Phase 1 dose-expansion study for luveltamab ta...

June 3, 2023, 8:00 pm

Sutro biopharma announces oral presentation at asco 2023 featuring data for luveltamab tazevibulin from the phase 1 dose-expansion study in ovarian cancer and the initiation of the phase 2/3 pivotal s

– Consistent with data shared in January 2023, the presentation at ASCO 2023 highlights data from the Phase 1 dose-expansion study for luveltamab ta...

June 3, 2023, 8:00 pm

Sutro biopharma announces oral presentation at asco 2023 featuring data for luveltamab tazevibulin from the phase 1 dose-expansion study in ovarian cancer and the initiation of the phase 2/3 pivotal s

– Consistent with data shared in January 2023, the presentation at ASCO 2023 highlights data from the Phase 1 dose-expansion study for luveltamab ta...

June 3, 2023, 8:00 pm

Sutro biopharma announces oral presentation at asco 2023 featuring data for luveltamab tazevibulin from the phase 1 dose-expansion study in ovarian cancer and the initiation of the phase 2/3 pivotal s

– Consistent with data shared in January 2023, the presentation at ASCO 2023 highlights data from the Phase 1 dose-expansion study for luveltamab ta...

June 3, 2023, 8:00 pm

Sutro biopharma announces oral presentation at asco 2023 featuring data for luveltamab tazevibulin from the phase 1 dose-expansion study in ovarian cancer and the initiation of the phase 2/3 pivotal s

– Consistent with data shared in January 2023, the presentation at ASCO 2023 highlights data from the Phase 1 dose-expansion study for luveltamab ta...

June 3, 2023, 8:00 pm

Sutro biopharma announces oral presentation at asco 2023 featuring data for luveltamab tazevibulin from the phase 1 dose-expansion study in ovarian cancer and the initiation of the phase 2/3 pivotal s

– Consistent with data shared in January 2023, the presentation at ASCO 2023 highlights data from the Phase 1 dose-expansion study for luveltamab ta...

June 3, 2023, 8:00 pm

Sutro biopharma announces oral presentation at asco 2023 featuring data for luveltamab tazevibulin from the phase 1 dose-expansion study in ovarian cancer and the initiation of the phase 2/3 pivotal s

– Consistent with data shared in January 2023, the presentation at ASCO 2023 highlights data from the Phase 1 dose-expansion study for luveltamab ta...

June 3, 2023, 8:00 pm

Sutro biopharma announces oral presentation at asco 2023 featuring data for luveltamab tazevibulin from the phase 1 dose-expansion study in ovarian cancer and the initiation of the phase 2/3 pivotal s

– Consistent with data shared in January 2023, the presentation at ASCO 2023 highlights data from the Phase 1 dose-expansion study for luveltamab ta...

June 3, 2023, 8:00 pm

Sutro biopharma announces oral presentation at asco 2023 featuring data for luveltamab tazevibulin from the phase 1 dose-expansion study in ovarian cancer and the initiation of the phase 2/3 pivotal s

– Consistent with data shared in January 2023, the presentation at ASCO 2023 highlights data from the Phase 1 dose-expansion study for luveltamab ta...

June 3, 2023, 8:00 pm


Search within

Pages Search Results: